Clinical Trial Update: A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease [Phase 3]

View source ↗

Summary

A Phase 3 placebo-controlled study of oral ozanimod as maintenance therapy for moderately to severely active Crohn's disease was terminated, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Zeposia (ozanimod hydrochloride)

Snippet

Sponsor: Celgene | Conditions: Crohn Disease | Phase 3 | Status: TERMINATED | Results posted: 2025-10-09